| Page 1835 | Kisaco Research
 

Dr. Alessandro Riva

Executive Vice President, Oncology Therapeutics
Gilead

Dr. Alessandro Riva

Executive Vice President, Oncology Therapeutics
Gilead

Dr. Alessandro Riva

Executive Vice President, Oncology Therapeutics
Gilead
 
Microbiome Invest 2019
23 May 2019
London
Microbiome Invest 2019 is dedicated to showcasing the most innovative emerging companies and academics with commercially viable research that manipulates the microbiome. Active investors and multinational nutrition and health companies will also share their knowledge and perspectives on commercialisation and discuss the most cutting-edge products and research in the microbiome space.
Pet Retail Strategies
Spotlight on...FitSkin
 

Samuel Bjork

Principal
Digitalis Ventures

Samuel Bjork

Principal
Digitalis Ventures

Samuel Bjork

Principal
Digitalis Ventures
 

Matthew Bell

Managing Director
Cultivian Sandbox Venture Fund

Matthew Bell

Managing Director
Cultivian Sandbox Venture Fund

Matthew Bell

Managing Director
Cultivian Sandbox Venture Fund
 

Doug Sterkel

President
Sterkel Crotty Investment Banking

Doug Sterkel

President
Sterkel Crotty Investment Banking

Doug Sterkel

President
Sterkel Crotty Investment Banking